Illumina, Inc. (LON:0J8Z)
113.63
-3.33 (-2.84%)
Feb 12, 2026, 5:00 PM GMT
Illumina Revenue
In the year 2025, Illumina had annual revenue of $4.34B USD, down -0.66%. Illumina had revenue of $1.16B in the quarter ending December 28, 2025, with 4.98% growth.
Revenue
$4.34B
Revenue Growth
-0.66%
P/S Ratio
4.05
Revenue / Employee
$480.95K
Employees
9,030
Market Cap
13.03B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 4.34B | -29.00M | -0.66% |
| Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
| Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
| Dec 30, 2018 | 3.33B | 581.00M | 21.11% |
| Dec 31, 2017 | 2.75B | 354.00M | 14.76% |
| Jan 1, 2017 | 2.40B | 178.00M | 8.02% |
| Jan 3, 2016 | 2.22B | 358.64M | 19.27% |
| Dec 28, 2014 | 1.86B | 440.18M | 30.97% |
| Dec 29, 2013 | 1.42B | 272.66M | 23.74% |
| Dec 30, 2012 | 1.15B | 92.98M | 8.81% |
| Jan 1, 2012 | 1.06B | 152.79M | 16.93% |
| Jan 2, 2011 | 902.74M | 236.42M | 35.48% |
| Jan 3, 2010 | 666.32M | 93.10M | 16.24% |
| Dec 28, 2008 | 573.23M | 206.43M | 56.28% |
| Dec 30, 2007 | 366.80M | 182.21M | 98.71% |
| Dec 31, 2006 | 184.59M | 111.09M | 151.13% |
| Jan 1, 2006 | 73.50M | 22.92M | 45.31% |
| Jan 2, 2005 | 50.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Illumina News
- 13 days ago - Illumina finishes SomaLogic acquisition - Seeking Alpha
- 13 days ago - Illumina completes acquisition of SomaLogic - PRNewsWire
- 17 days ago - Illumina (ILMN) Sees Raised Price Target and Maintained 'Buy' Rating by Guggenheim | ILMN Stock News - GuruFocus
- 17 days ago - Illumina (ILMN) Maintains Hold Rating with Increased Price Target | ILMN Stock News - GuruFocus
- 21 days ago - Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Benzinga
- 21 days ago - Tema Oncology ETF Sells 2,990 Shares of Illumina Inc (ILMN) - GuruFocus
- 22 days ago - Independence Bank of Kentucky Buys 15 Shares of Illumina Inc (ILMN) - GuruFocus
- 23 days ago - ILMN Stock: Stifel Raises Price Target, Maintains Buy Rating | ILMN Stock News - GuruFocus